Sio Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Sio Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,500	Closed	-$4.63M	–	79
2021 Q3	$4.63M	Buy	25,500 +1,600	+7%	+$312K	1.47%	20
2021 Q2	$4.82M	Buy	23,900 +2,833	+13%	+$593K	1.2%	27
2021 Q1	$4.53M	Sell	21,067 -5,133	-20%	-$1.13M	0.92%	39
2020 Q4	$6.19M	Buy	+26,200	New	+$6.01M	1.27%	25
2019 Q3	–	Sell	-28,232	Closed	-$5.18M	–	88
2019 Q2	$5.18M	Hold	28,232	–	–	1.25%	27
2019 Q1	$5.19M	Buy	+28,232	New	+$5.21M	1.4%	26
2018 Q1	–	Sell	-14,874	Closed	-$2.23M	–	48
2017 Q4	$2.23M	Hold	14,874	–	–	1.26%	30
2017 Q3	$2.26M	Buy	+14,874	New	+$2.24M	1.17%	31
2017 Q2	–	Sell	-19,475	Closed	-$2.13M	–	70
2017 Q1	$2.13M	Buy	+19,475	New	+$1.71M	1.19%	27

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sio Capital Management's VRTX Position: Q4 2021 in Review

Sio Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 25,500 shares — an estimated $4.63M sold.

Sio Capital Management first reported a position in VRTX in Q1 2017 and held it in 9 quarters. The position peaked at $6.19M in Q4 2020. 1,034 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

Sio Capital Management reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Sio Capital Management sold 25,500 Vertex Pharmaceuticals shares in Q4 2021, an estimated $4.63M.
Sio Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2017 and held it in 9 quarters.
Sio Capital Management's Vertex Pharmaceuticals position peaked at $6.19M in Q4 2020.
1,034 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Sio Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.